Last May 9, on the occasion of Europe Day, Catalonia.health was present at the institutional event commemorating the 40th anniversary of the accession of Catalonia and Spain to the European Union. Representing the presidency of the association and its associates, the vice-president of Catalonia.health, Pau Turón, attended.

Asabys Partners, a venture capital firm specialized in life sciences and a member of Catalonia.health, has been selected in the Innvierte Deep Start call, promoted by the Center for Technological Development and Innovation (CDTI) in collaboration with the European Investment Fund (FEI), within the framework of Spain's National Deep Tech Strategy 2026-2030.

Integra Therapeutics, member of Catalonia.health, has presented new preclinical results of its FiCAT platform at the American Society for Gene and Cell Therapy (ASGCT) congress.

The Connection Day 2026, organized by Catalonia.health, has celebrated its fourth edition with a notable success in terms of participation and content. The event, held on May 6 at the World Trade Center in Barcelona, was consolidated as the reference B2B meeting point for the health sector in Catalonia, where more than 250 professionals from the entire value chain gathered: startups, companies, investors, hospitals, research centers and institutions.

Majesty King Felipe VI has inaugurated the CaixaResearch Institute, the first center dedicated entirely to the study of immunology in Spain and Portugal, and one of the pioneers in Europe. The new institute, promoted by the "la Caixa" Foundation and a Catalonia.health member, represents an investment of €100 million and strengthens Catalonia's biomedical research ecosystem.

Catalan company INBRAIN Neuroelectronics, a member of Catalonia.health, has announced the completion of patient enrolment in its first-in-human study of graphene-based neural interfaces for brain decoding and mapping.

Catalan biotech company Aniling, a member of Catalonia.health, has announced a strategic collaboration with Illumina to advance unified genomic and epigenetic assays in oncology.

Catalan biotech company Sequentia Biotech, a member of Catalonia.health, has announced the achievement of CE-IVD marking under the new European IVDR regulation for its MICK Clinical™ solution, designed for gastrointestinal pathogen diagnostics.

Kymos Group, a European contract research organization specialized in services for the biopharmaceutical industry and a Catalonia.health’s member, has announced the acquisition of Particle Analytical ApS, a Danish company specialized in particle analysis and solid-state characterization.

Croda International Plc, a global leader in specialty ingredients and a Catalonia.health member company, has announced a strategic supply partnership with Amino GmbH, a leading manufacturer of pharmaceutical-grade amino acids, aimed at strengthening the global availability of high purity amino acids for pharmaceutical formulation and biomanufacturing.